149 related articles for article (PubMed ID: 8630122)
1. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.
Kuwana M; Fujii T; Mimori T; Kaburaki J
Arthritis Rheum; 1996 Apr; 39(4):686-91. PubMed ID: 8630122
[TBL] [Abstract][Full Text] [Related]
2. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.
McHugh NJ; Whyte J; Harvey G; Haustein UF
Arthritis Rheum; 1994 Aug; 37(8):1198-205. PubMed ID: 8053959
[TBL] [Abstract][Full Text] [Related]
3. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
4. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
5. Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Glaeser L; Henes J; Kötter I; Vogel W; Kanz L; Klein R
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):28-35. PubMed ID: 29465357
[TBL] [Abstract][Full Text] [Related]
6. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
7. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
8. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.
Martínez-Cordero E; Trejo AP; León DE
J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342
[TBL] [Abstract][Full Text] [Related]
9. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
Front Immunol; 2021; 12():786039. PubMed ID: 34956217
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Henes J; Glaeser L; Kötter I; Vogel W; Kanz L; Klein R
Rheumatology (Oxford); 2017 Mar; 56(3):451-456. PubMed ID: 27940597
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
Kuwana M; Medsger TA; Wright TM
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):266-78. PubMed ID: 7554448
[TBL] [Abstract][Full Text] [Related]
12. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
13. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis.
Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T
Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562
[TBL] [Abstract][Full Text] [Related]
16. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.
Verheijen R; de Jong BA; van Venrooij WJ
Clin Exp Immunol; 1992 Sep; 89(3):456-60. PubMed ID: 1325307
[TBL] [Abstract][Full Text] [Related]
17. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
[TBL] [Abstract][Full Text] [Related]
18. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.
Kato T; Yamamoto K; Takeuchi H; Okubo M; Hara E; Nakada S; Oda K; Ito K; Nishioka K
Arthritis Rheum; 1993 Nov; 36(11):1580-7. PubMed ID: 7694585
[TBL] [Abstract][Full Text] [Related]
19. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
[TBL] [Abstract][Full Text] [Related]
20. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
